New method
CA 2440845 A1 · Owner: Biovitrum Ab · Inventors: Ekblom, Jonas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a method for identifying RNA-binding molecules comprising the steps of: predicting the structure of an RNA-fragment by an in silico method, choosing a suitable predicted RNA-fragment synthesizing the , cDNA-fragment corresponding to the predicted RNA-fragment inserting the cDNA-, fragment in the upstream proximity of a reporter assay gene which reporter , assay gene produces a signal upon translation thereby forming a reporter , construct and performing a reporter gene assay, which assay monitors the interaction between a molecule to be tested for RNA-binding and the RNAfragment of the reporter construct. Furthermore the invention relates to the , use of specific …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 4, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 4, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 4, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.